| GENMAB AS DK 1 | 271.500 / -4.77% |
| Date/Time | 03/03 / 12:30 |
| Chg. / Chg.(%) | -13.600 / -4.77% |
| Bid | 272.900 / 200 |
| Ask | 274.300 / 200 |
| Open | 280.800 |
| Previous Close | 285.100 |
| High | 280.800 |
| Low | 271.500 |
| Volume [EUR] | - |
| Volume [Units] | |
| Price fixings | 5 |
| ISIN | DK0010272202 |
| Security | GE9 |
| Exchange | Stuttgart |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Cboe Europe .. | 2,031.00 |  |
29,459 |
| Turquoise | 2,031.00 | |
8,526 |
| London Inter.. | 2,030.0 | |
3,078 |
| Cboe Europe .. | 2,028.50 | |
170 |
| TradeGate | 272.700 | |
85 |
| Cboe Europe .. | 2,045.00 | |
65 |
| Frankfurt | 275.2000 | |
12 |
| gettex | 272.600 | |
3 |
| Vienna Globa.. | 278.20 | |
0 |
| München | 284.70 | |
0 |
| Düsseldorf | 272.40 | |
0 |
| Berlin | 274.00 | |
0 |
| Lang & Schwa.. | 272.90 | |
|
| Stuttgart | 271.500 | |
|
| OMX Nordic | 2,102.00 | |
189,102 |
| Nasdaq Other.. | 338.2800 | |
372 |
| Mexico | 7,638.15 | |
11,330 |
News
- Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
02/25/2021 / 20:53 - GlobeNewswire - Genmab announces initiation of share buy-back program
02/23/2021 / 17:05 - GlobeNewswire - Genmab Publishes 2020 Annual Report
02/23/2021 / 17:00 - GlobeNewswire - Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines
02/22/2021 / 14:00 - GlobeNewswire - Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer
02/10/2021 / 22:05 - GlobeNewswire
Real-time